CN113861053A - Preparation method of tri (hydroxymethyl) methylglycine - Google Patents

Preparation method of tri (hydroxymethyl) methylglycine Download PDF

Info

Publication number
CN113861053A
CN113861053A CN202111129423.XA CN202111129423A CN113861053A CN 113861053 A CN113861053 A CN 113861053A CN 202111129423 A CN202111129423 A CN 202111129423A CN 113861053 A CN113861053 A CN 113861053A
Authority
CN
China
Prior art keywords
compound
acid
reaction
hydroxymethyl
methylglycine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202111129423.XA
Other languages
Chinese (zh)
Other versions
CN113861053B (en
Inventor
袁永坤
蒋玉贵
朱胜恺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Yacoo Science Co ltd
Original Assignee
Suzhou Yacoo Science Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou Yacoo Science Co ltd filed Critical Suzhou Yacoo Science Co ltd
Priority to CN202111129423.XA priority Critical patent/CN113861053B/en
Publication of CN113861053A publication Critical patent/CN113861053A/en
Priority to PCT/CN2022/111366 priority patent/WO2023045601A1/en
Application granted granted Critical
Publication of CN113861053B publication Critical patent/CN113861053B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/02Formation of carboxyl groups in compounds containing amino groups, e.g. by oxidation of amino alcohols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38Separation; Purification; Stabilisation; Use of additives
    • C07C227/40Separation; Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to the technical field of biological buffers, and discloses a preparation method of tri (hydroxymethyl) methylglycine, which comprises the following preparation steps: reacting the compound I with the compound A to obtain a compound II; and (3) carrying out at least one of hydrolysis reaction, oxidation reaction and acid-base treatment reaction on the compound II to obtain a crude product of the tris (hydroxymethyl) methylglycine, and purifying to obtain a refined product of the tris (hydroxymethyl) methylglycine. The preparation method disclosed by the invention has the advantages that the cost of the raw materials used in the preparation method is low, the operation is simple, the purity of the obtained product is higher, the yield of the product is improved, the application cost of the product is reduced, the obtained product meets the requirements of the biological buffer agent field on the purity, the impurity content, the cost and the like, and the method is suitable for industrial production and is suitable for application in the biological buffer agent field.

Description

Preparation method of tri (hydroxymethyl) methylglycine
Technical Field
The invention relates to the technical field of biological buffers, in particular to a preparation method of tri (hydroxymethyl) methylglycine.
Background
Tris (hydroxymethyl) methylglycine, Tricine for short, CAS 5704-04-1, is a zwitterionic buffer used in biochemistry and molecular biology. Tricine has pH buffer range of 7.4-8.8, is mainly used for substituting glycine, and is applied to small molecule protein electrophoresis in cooperation with SDS (sodium dodecyl sulfate); in biochemical research, the method is commonly used in biochemical diagnostic kits, DNA/RNA extraction kits and PCR diagnostic kits.
Patent CN112194590A discloses a method for preparing tris (hydroxymethyl) methylglycine, which comprises reacting sodium chloroacetate and tris (hydroxymethyl) aminomethane in methanol, controlling the pH value within the range of 8-10, then cooling, adding concentrated sulfuric acid, crystallizing, drying and the like to obtain tris (hydroxymethyl) methylglycine. The preparation method has the defects of strict control of reaction conditions, complex preparation process, low product purity, high product impurity and the like. Therefore, it is highly desirable to provide a method for preparing tris (hydroxymethyl) methylglycine with simple production method, high product purity and high yield.
Disclosure of Invention
In order to overcome the defects of the prior art, the invention aims to provide the preparation method of the tris (hydroxymethyl) methylglycine, the raw materials used in the preparation method are low in cost, the operation is simple, the yield of the prepared product is high, the crude tris (hydroxymethyl) methylglycine obtained by the preparation method is purified to obtain the refined tris (hydroxymethyl) methylglycine with high purity, and the requirements of the biological buffer agent field on the purity, the impurity content, the cost and the like of the refined tris (hydroxymethyl) methylglycine are met.
The invention is realized by adopting the following technical scheme:
a preparation method of tris (hydroxymethyl) methylglycine comprises the following preparation steps:
preparation step S1: reacting the compound I with the compound A to obtain a compound II;
preparation step S2: carrying out at least one reaction of hydrolysis reaction, oxidation reaction and acid-base treatment reaction on the compound II to obtain tri (hydroxymethyl) methylglycine;
the acid-base treatment reaction comprises at least one of acid treatment and alkali treatment;
wherein, the compound I is trihydroxymethyl aminomethane;
the compound A is
Figure BDA0003280009120000021
Or a salt thereof,
Figure BDA0003280009120000022
Or a salt thereof,
Figure BDA0003280009120000023
Or a salt thereof,
Figure BDA0003280009120000024
Y is halogen, OH, SH, ester corresponding to OH and ester corresponding to SH.
Preferably, the compound A is
Figure BDA0003280009120000025
At least one of, the Y1、Y2Are halogen, OH, SH, esters corresponding to OH, esters corresponding to SH;
preferably, the compound A is at least one of bromoacetic acid, an ester corresponding to bromoacetic acid, an acid anhydride corresponding to bromoacetic acid, a mixed acid anhydride corresponding to bromoacetic acid, a bromoacetate salt, iodoacetic acid, an ester corresponding to iodoacetic acid, an acid anhydride corresponding to iodoacetic acid, a mixed acid anhydride corresponding to iodoacetic acid, and an iodoacetate salt.
Preferably, the compound A is at least one of ester corresponding to chloroacetic acid, anhydride corresponding to chloroacetic acid and mixed anhydride corresponding to chloroacetic acid.
Preferably, the compound A is at least one of formaldehyde, paraformaldehyde, cyanuric acid and cyanide MCN, and N is one of metal positive ions, inorganic ammonium positive ions and organic amine positive ions.
The reaction equation of the preparation step S1 is shown by the following formula (1):
Figure BDA0003280009120000031
the reaction equation of the preparation step S2 is shown in the following formula (2):
Figure BDA0003280009120000032
preferably, the ester mentioned in the compound A is at least one of carboxylate, sulfonate, sulfinate and inorganic acid ester.
Preferably, the salt mentioned in the compound A is at least one of metal salt, ammonium salt and complex salt based on acid-base action.
Preferably, in the preparation step S2, the oxidizing agent used in the oxidation reaction of the compound II is at least one of peroxide, ozone, permanganic acid, permanganate, dichromic acid, dichromate, hypochlorous acid, hypochlorite, chlorous acid, chlorite, fluorine gas, a fluorine-containing gas mixture, chlorine gas, bromine, iodine, manganese dioxide, nitric acid, m-chlorobenzoic acid, m-chlorobenzoate, sulfuric acid, peroxymonosulfuric acid, peroxymonosulfate, dithionic acid, dithionate, pyrosulfuric acid, pyrosulfate, oxygen, caro acid, m-chloroperoxybenzoic acid, m-chloroperoxybenzoate, sulfur dioxide, and nitrogen dioxide.
Preferably, in the preparation step S1, the molar ratio of compound I to compound a is 1: (0.1 to 10); in preparation step S2, the molar ratio of compound II to oxidizing agent is 1: (0.1-10).
Preferably, in the preparation step S1, the reaction temperature is-50 ℃ to 200 ℃, the reaction pressure is-0.05 MPa to 1MPa, and the reaction time is 0.1h to 72 h; in the preparation step S2, the reaction temperature is-50 ℃ to 200 ℃, the reaction pressure is-0.05 MPa to 1MPa, and the reaction time is 0.1h to 72 h.
Preferably, in the preparation step S1, compound I is reacted with compound a in a reaction solvent a, wherein the reaction solvent a is at least one of methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl ether, acetonitrile, dioxane, N-dimethylformamide, water, and dimethyl sulfoxide; in the preparation step S2, the compound II is reacted in a reaction solvent B, which is at least one of methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl ether, acetonitrile, dioxane, N-dimethylformamide, water, and dimethyl sulfoxide.
The preparation method of the tri (hydroxymethyl) methylglycine further comprises the following preparation steps:
under a dry condition, the crude tris (hydroxymethyl) methylglycine obtained in the preparation step S2 is dissolved in a purification solvent by using a dry closed device or under dry gas purging, and then recrystallization is performed, followed by crystallization, filtration and drying under a low temperature condition, so as to obtain the refined tris (hydroxymethyl) methylglycine.
The purifying solvent is at least one of methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl ether, acetonitrile, dioxane, N-dimethylformamide, water and dimethyl sulfoxide.
Compared with the prior art, the invention has the beneficial effects that:
the preparation method disclosed by the invention has the advantages that the cost of the raw materials used in the preparation method is low, the operation is simple, the purity of the obtained product is higher, the yield of the product is improved, the application cost of the product is reduced, the obtained product meets the requirements of the biological buffer agent field on the purity, the impurity content, the cost and the like, and the method is suitable for industrial production and is suitable for application in the biological buffer agent field.
According to the preparation method, the compound I which is easy to obtain and low in cost is selected to react with the compound A to generate the compound II, and then the compound II is subjected to hydrolysis reaction, oxidation reaction, acid-base treatment reaction and other reactions to obtain the tri (hydroxymethyl) methylglycine.
The product obtained by the preparation process is easy to purify and separate, and by-products and impurities generated in the reaction process can meet the application standard of the field of biological buffers on high purity, so that the requirements of various aspects of large-scale production and application are met.
The whole preparation process is simple and easy to control, is favorable for enlarging production, shortens the reaction production period, can obtain the tri (hydroxymethyl) methylglycine with higher purity through conventional recrystallization purification, and can effectively improve the yield of the product.
Detailed Description
The present invention is further described below with reference to specific embodiments, and it should be noted that, without conflict, any combination between the embodiments or technical features described below may form a new embodiment. It is noted that the terminology used in the examples is for the purpose of describing particular embodiments only and is not intended to limit the scope of the present invention. In addition, the raw materials used in the invention are all common commercial products, so that the sources of the raw materials do not need to be particularly limited.
The pressure values mentioned in the present invention are, if not specified otherwise, gauge pressures, which are the total absolute pressure exceeding the ambient atmospheric pressure or the pressure at a point in the liquid above atmospheric pressure.
The yield is the percentage ratio of the actual product mass to the theoretical product mass, which is calculated with no excess of starting materials in the reaction equation.
In the following examples, the test methods: nuclear magnetic analysis testing using an AVANCE 400 mega nuclear magnetic resonance spectrometer from Bruker (Bruker); the purity of the product was determined by an acid-base titrator.
Example 1
A preparation method of tris (hydroxymethyl) methylglycine comprises the following preparation steps:
preparation step S1:
under the condition of stirring, 20g of compound I, trihydroxymethyl aminomethane, compound A and reaction solvent ethanol are added into a 1L drying reactor, the molar ratio of the compound I to the compound A is 1:1 respectively, the temperature of a reaction oil bath is 60 ℃, the reaction pressure is 0MPa (gauge pressure), and the reaction time is 4 h.
Cooling to normal temperature after the reaction is finished, filtering to remove insoluble substances, performing rotary evaporation on the filtrate under reduced pressure to remove the solvent, and concentrating to obtain a crude compound II;
wherein the compound A is
Figure BDA0003280009120000061
Y is Cl.
Preparation step S2:
under the condition of stirring, 20g of a compound II and a reaction solvent ethanol are added into a 1L drying reactor, an oxidation reagent hydrogen peroxide is added, the molar ratio of the compound II to the oxidation reagent is 1:3 respectively, the temperature of a reaction oil bath is 65 ℃, the reaction pressure is 0MPa (gauge pressure), and the reaction time is 6 h.
And (3) cooling to normal temperature after the reaction is finished, filtering to remove insoluble substances, performing rotary evaporation on the filtrate under reduced pressure to remove the solvent, and concentrating to obtain a crude product of the tris (hydroxymethyl) methylglycine, wherein the yield of the crude product is 90%.
Preparation step S3:
under the drying condition, the tris (hydroxymethyl) methylglycine of the crude product obtained in the preparation step S2 is dissolved in a purification solvent ethanol by using a drying closed device, then recrystallization is carried out, crystallization, filtration and drying are carried out under the low temperature condition, and the refined tris (hydroxymethyl) methylglycine refined product with the purity of 99.5 percent is obtained.
The nuclear magnetic resonance characterization data of the product is as follows:
1H NMR(400MHz,D2O)δ3.8ppm(6H),3.7ppm(2H)。
example 2
A preparation method of tris (hydroxymethyl) methylglycine comprises the following preparation steps:
preparation step S1:
under the condition of stirring, 20g of compound I, tris (hydroxymethyl) aminomethane, compound A and a reaction solvent methanol were added into a 1L dry reactor, the molar ratio of compound I to compound A was 1:1.05, the reaction oil bath temperature was 60 ℃, the reaction pressure was 0.01MPa (gauge pressure), and the reaction time was 4 hours.
Cooling to normal temperature after the reaction is finished, filtering to remove insoluble substances, performing rotary evaporation on the filtrate under reduced pressure to remove the solvent, and concentrating to obtain a crude compound II;
wherein the compound A is
Figure BDA0003280009120000071
Y is OH.
Preparation step S2:
under the condition of stirring, 20g of compound II and a reaction solvent methanol are added into a 1L drying reactor, hydrolysis reaction and acid-base treatment are carried out on the compound II and water, the temperature of a reaction oil bath is 94 ℃, the reaction pressure is 0.015MPa (gauge pressure), and the reaction time is 6 h.
And (3) cooling to normal temperature after the reaction is finished, filtering to remove insoluble substances, performing rotary evaporation on the filtrate under reduced pressure to remove the solvent, and concentrating to obtain a crude product of the tris (hydroxymethyl) methylglycine, wherein the yield of the crude product is 93%.
Preparation step S3:
under the drying condition, the tris (hydroxymethyl) methylglycine of the crude product obtained in the preparation step S2 is dissolved in a purification solvent ethanol by using a drying closed device, then recrystallization is carried out, crystallization, filtration and drying are carried out under the low temperature condition, and the refined tris (hydroxymethyl) methylglycine refined product with the purity of 99.6 percent is obtained.
The nuclear magnetic resonance characterization data of the product is as follows:
1H NMR(400MHz,D2O)δ3.8ppm(6H),3.7ppm(2H)。
example 3
A preparation method of tris (hydroxymethyl) methylglycine comprises the following preparation steps:
preparation step S1:
under the condition of stirring, 20g of compound I, trihydroxymethyl aminomethane, compound A and reaction solvent acetonitrile are added into a 1L drying reactor, the molar ratio of the compound I to the compound A is respectively 1:2, the temperature of a reaction oil bath is 60 ℃, the reaction pressure is-0.01 MPa (gauge pressure), and the reaction time is 4 h.
Cooling to normal temperature after the reaction is finished, filtering to remove insoluble substances, performing rotary evaporation on the filtrate under reduced pressure to remove the solvent, and concentrating to obtain a crude compound II;
wherein the compound A is
Figure BDA0003280009120000081
Y is Br.
Preparation step S2:
under the condition of stirring, 20g of compound II and acetonitrile serving as a reaction solvent are added into a 1L drying reactor, water is added, hydrolysis reaction is carried out on the compound II and the water, the temperature of a reaction oil bath is 90 ℃, the reaction pressure is 0.02MPa (gauge pressure), the reaction time is 6h, and acid-base treatment reaction is carried out.
And (3) cooling to normal temperature after the reaction is finished, filtering to remove insoluble substances, performing rotary evaporation on the filtrate under reduced pressure to remove the solvent, and concentrating to obtain a crude product of the tris (hydroxymethyl) methylglycine, wherein the yield of the crude product is 94%.
Preparation step S3:
under the drying condition, the tris (hydroxymethyl) methylglycine of the crude product obtained in the preparation step S2 is dissolved in a purification solvent acetonitrile by using a drying closed device, then recrystallization is carried out, crystallization, filtration and drying are carried out under the low temperature condition, and the refined tris (hydroxymethyl) methylglycine refined product with the purity of 99.7 percent is obtained.
The nuclear magnetic resonance characterization data of the product is as follows:
1H NMR(400MHz,D2O)δ3.8ppm(6H),3.7ppm(2H)。
example 4
A preparation method of tris (hydroxymethyl) methylglycine comprises the following preparation steps:
preparation step S1:
under the condition of stirring, 20g of a mixture of compound I, tris (hydroxymethyl) aminomethane, compound A, a reaction solvent ethanol and water was added to a 1L dry reactor, the molar ratio of compound I to compound A was 1:4, the reaction oil bath temperature was 60 ℃, the reaction pressure was 0MPa (gauge pressure), and the reaction time was 4 hours.
Cooling to normal temperature after the reaction is finished, filtering to remove insoluble substances, performing rotary evaporation on the filtrate under reduced pressure to remove the solvent, and concentrating to obtain a crude compound II;
wherein the compound A is
Figure BDA0003280009120000091
Y1、Y2Are all Cl.
Preparation step S2:
under the condition of stirring, 20g of a compound II and a reaction solvent dichloromethane are added into a 1L drying reactor, an oxidation reagent potassium permanganate is added, the molar ratio of the compound II to the oxidation reagent is 1:3 respectively, the temperature of a reaction oil bath is 65 ℃, the reaction pressure is-0.01 MPa (gauge pressure), and the reaction time is 6 h.
And (3) cooling to normal temperature after the reaction is finished, filtering to remove insoluble substances, performing rotary evaporation on the filtrate under reduced pressure to remove the solvent, and concentrating to obtain a crude product of the tris (hydroxymethyl) methylglycine, wherein the yield of the crude product is 64%.
Preparation step S3:
under the drying condition, the crude product of the tris (hydroxymethyl) methylglycine obtained in the preparation step S2 is dissolved in a mixture of a purification solvent ethanol and water by using a drying closed device, then recrystallization is carried out, and crystallization, filtration and drying are carried out under the low-temperature condition, so as to obtain the refined tris (hydroxymethyl) methylglycine product with the purity of 99.5%.
The nuclear magnetic resonance characterization data of the product is as follows:
1H NMR(400MHz,D2O)δ3.8ppm(6H),3.7ppm(2H)。
example 5
A preparation method of tris (hydroxymethyl) methylglycine comprises the following preparation steps:
preparation step S1:
under the condition of stirring, 20g of a mixture of compound I, tris (hydroxymethyl) aminomethane, compound A, a reaction solvent methanol and water was added to a 1L dry reactor, the molar ratio of compound I to compound A was 1:2, the reaction oil bath temperature was 60 ℃, the reaction pressure was 0MPa (gauge pressure), and the reaction time was 4 hours.
Cooling to normal temperature after the reaction is finished, filtering to remove insoluble substances, performing rotary evaporation on the filtrate under reduced pressure to remove the solvent, and concentrating to obtain a crude compound II;
wherein, the compound A is sodium bromoacetate.
Preparation step S2:
under the condition of stirring, 20g of compound II is added into a 1L drying reactor, and after acid-base treatment reaction, sodium salt is changed into corresponding acid, the temperature of a reaction oil bath is 65 ℃, the reaction pressure is 0MPa (gauge pressure), and the reaction time is 6 h.
And (3) cooling to normal temperature after the reaction is finished, filtering to remove insoluble substances, performing rotary evaporation on the filtrate under reduced pressure to remove the solvent, and concentrating to obtain a crude product of the tris (hydroxymethyl) methylglycine, wherein the yield of the crude product is 93%.
Preparation step S3:
under the drying condition, the crude product of the tris (hydroxymethyl) methylglycine obtained in the preparation step S2 is dissolved in a mixture of a purification solvent methanol and water by using a drying closed device, then recrystallization is carried out, and crystallization, filtration and drying are carried out under the low-temperature condition, so as to obtain the refined tris (hydroxymethyl) methylglycine product with the purity of 99.6%.
The nuclear magnetic resonance characterization data of the product is as follows:
1H NMR(400MHz,D2O)δ3.8ppm(6H),3.7ppm(2H)。
example 6
A preparation method of tris (hydroxymethyl) methylglycine comprises the following preparation steps:
preparation step S1:
under the condition of stirring, 20g of compound I, trihydroxymethyl aminomethane, compound A and reaction solvent methanol are added into a 1L drying reactor, the molar ratio of the compound I to the compound A is 1:1 respectively, the temperature of a reaction oil bath is 60 ℃, the reaction pressure is 0MPa (gauge pressure), and the reaction time is 4 h.
Cooling to normal temperature after the reaction is finished, filtering to remove insoluble substances, performing rotary evaporation on the filtrate under reduced pressure to remove the solvent, and concentrating to obtain a crude compound II;
wherein, the compound A is ethyl ester corresponding to chloroacetic acid.
Preparation step S2:
under the condition of stirring, 20g of compound II is added into a 1L drying reactor, and after acid-base treatment reaction, ester is converted into corresponding acid, the temperature of a reaction oil bath is 65 ℃, the reaction pressure is 0MPa (gauge pressure), and the reaction time is 6 h.
And (3) cooling to normal temperature after the reaction is finished, filtering to remove insoluble substances, performing rotary evaporation on the filtrate under reduced pressure to remove the solvent, and concentrating to obtain a crude product of the tris (hydroxymethyl) methylglycine, wherein the yield of the crude product is 92%.
Preparation step S3:
under the drying condition, the tris (hydroxymethyl) methylglycine of the crude product obtained in the preparation step S2 is dissolved in a purification solvent ethanol by using a drying closed device, then recrystallization is carried out, crystallization, filtration and drying are carried out under the low temperature condition, and the refined tris (hydroxymethyl) methylglycine refined product with the purity of 99.5 percent is obtained.
The nuclear magnetic resonance characterization data of the product is as follows:
1H NMR(400MHz,D2O)δ3.8ppm(6H),3.7ppm(2H)。
example 7
A preparation method of tris (hydroxymethyl) methylglycine comprises the following preparation steps:
preparation step S1:
under the condition of stirring, 20g of compound I, trihydroxymethyl aminomethane, compound A and reaction solvent ethanol are added into a 1L drying reactor, the molar ratio of the compound I to the compound A is respectively 1:3, the temperature of a reaction oil bath is 60 ℃, the reaction pressure is 0MPa (gauge pressure), and the reaction time is 4 h.
Cooling to normal temperature after the reaction is finished, filtering to remove insoluble substances, performing rotary evaporation on the filtrate under reduced pressure to remove the solvent, and concentrating to obtain a crude compound II;
wherein, the compound A is a mixture of paraformaldehyde and cyanide NaCN.
Preparation step S2:
under the condition of stirring, 20g of the compound II and a reaction solvent ethanol are added into a 1L drying reactor, water is added, hydrolysis reaction is carried out on the compound II and the water, the temperature of a reaction oil bath is 95 ℃, the reaction pressure is 0MPa (gauge pressure), and the reaction time is 6 h.
And (3) cooling to normal temperature after the reaction is finished, filtering to remove insoluble substances, performing rotary evaporation on the filtrate under reduced pressure to remove the solvent, and concentrating to obtain a crude product of the tris (hydroxymethyl) methylglycine, wherein the yield of the crude product is 52%.
Preparation step S3:
under the drying condition, the tris (hydroxymethyl) methylglycine of the crude product obtained in the preparation step S2 is dissolved in a purification solvent ethanol by using a drying closed device, then recrystallization is carried out, crystallization, filtration and drying are carried out under the low temperature condition, and the refined tris (hydroxymethyl) methylglycine refined product with the purity of 99.0 percent is obtained.
The nuclear magnetic resonance characterization data of the product is as follows:
1H NMR(400MHz,D2O)δ3.8ppm(6H),3.7ppm(2H)。
the experiments show that the tris (hydroxymethyl) methylglycine prepared in the embodiment has high purity and low impurity content, the yield of crude products can reach more than 94 percent at most, the purity of fine products can reach more than 99.5 percent, and the application requirements of biological buffers can be met.
The above embodiments are only preferred embodiments of the present invention, and the protection scope of the present invention is not limited thereby, and any insubstantial changes and substitutions made by those skilled in the art based on the present invention are within the protection scope of the present invention.

Claims (11)

1. A preparation method of tris (hydroxymethyl) methylglycine is characterized by comprising the following preparation steps:
preparation step S1: reacting the compound I with the compound A to obtain a compound II;
preparation step S2: carrying out at least one reaction of hydrolysis reaction, oxidation reaction and acid-base treatment reaction on the compound II to obtain tri (hydroxymethyl) methylglycine;
wherein, the compound I is trihydroxymethyl aminomethane;
the compound A is
Figure FDA0003280009110000011
Or a salt thereof,
Figure FDA0003280009110000012
Or a salt thereof,
Figure FDA0003280009110000013
Or a salt thereof,
Figure FDA0003280009110000014
Y is halogen, OH, SH, ester corresponding to OH and ester corresponding to SH.
2. The process for producing tris (hydroxymethyl) methylglycine according to claim 1, characterised in that compound a is
Figure FDA0003280009110000015
At least one of, the Y1、Y2Are halogen, OH, SH, esters corresponding to OH and esters corresponding to SH.
3. The process according to claim 1, wherein compound a is at least one of bromoacetic acid, an ester of bromoacetic acid, an anhydride of bromoacetic acid, a mixed anhydride of bromoacetic acid, a bromoacetate salt, iodoacetic acid, an ester of iodoacetic acid, an anhydride of iodoacetic acid, a mixed anhydride of iodoacetic acid, and an iodoacetate salt.
4. The method according to claim 1, wherein the compound A is at least one selected from an ester corresponding to chloroacetic acid, an anhydride corresponding to chloroacetic acid, and a mixed anhydride corresponding to chloroacetic acid.
5. The method of claim 1, wherein the compound A is at least one of formaldehyde, paraformaldehyde, cyanuric acid, and cyanide MCN, and N is one of metal cation, inorganic ammonium cation, and organic amine cation.
6. The method for producing tris (hydroxymethyl) methylglycine according to any one of claims 1 to 4, characterized in that the ester mentioned in the compound A is at least one of a carboxylate, a sulfonate, a sulfinate, an inorganic acid ester; the salt mentioned in the compound A is at least one of metal salt, ammonium salt and complex salt based on acid-base action.
7. The method according to claim 1, wherein in step S2, the oxidizing agent used for oxidizing compound II is at least one selected from the group consisting of peroxide, ozone, permanganic acid, permanganate, dichromic acid, dichromate, hypochlorous acid, hypochlorite, chlorous acid, chlorite, fluorine gas, a mixed gas containing fluorine gas, chlorine gas, bromine, iodine, manganese dioxide, nitric acid, metachlorobenzoic acid, metachlorobenzoate, sulfuric acid, peroxymonosulfuric acid, peroxymonosulfate, dithionic acid, dithionate, pyrosulfuric acid, pyrosulfate, oxygen, caro' S acid, metachloroperbenzoic acid, metachloroperoxybenzoate, sulfur trioxide, and nitrogen dioxide.
8. The method according to claim 1, wherein in the step of S1, the molar ratio of compound I to compound a is 1: (0.1 to 10); in preparation step S2, the molar ratio of compound II to oxidizing agent is 1: (0.1-10).
9. The method for preparing tris (hydroxymethyl) methylglycine according to claim 1, wherein in the preparation step S1, the reaction temperature is-50 ℃ to 200 ℃, the reaction pressure is-0.05 MPa to 1MPa, and the reaction time is 0.1h to 72 h; in the preparation step S2, the reaction temperature is-50 ℃ to 200 ℃, the reaction pressure is-0.05 MPa to 1MPa, and the reaction time is 0.1h to 72 h.
10. The method according to claim 1, wherein in the step S1, compound I is reacted with compound a in a reaction solvent a, which is at least one selected from methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl ether, acetonitrile, dioxane, N-dimethylformamide, water, and dimethylsulfoxide; in the preparation step S2, the compound II is reacted in a reaction solvent B, which is at least one of methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl ether, acetonitrile, dioxane, N-dimethylformamide, water, and dimethyl sulfoxide.
11. A process for the preparation of tris (hydroxymethyl) methylglycine according to any one of claims 1 to 10, characterised by the further preparation steps of:
under the dry condition, dissolving the crude product of the tris (hydroxymethyl) methylglycine obtained in the preparation step S2 in a purification solvent by using dry closed equipment or under the dry gas purging, then recrystallizing, crystallizing, filtering and drying under the low temperature condition to obtain refined tris (hydroxymethyl) methylglycine;
the purifying solvent is at least one of methanol, ethanol, acetone, tetrahydrofuran, ethyl acetate, dimethyl carbonate, diethyl ether, acetonitrile, dioxane, N-dimethylformamide, water and dimethyl sulfoxide.
CN202111129423.XA 2021-09-26 2021-09-26 Preparation method of tris (hydroxymethyl) methylglycine Active CN113861053B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202111129423.XA CN113861053B (en) 2021-09-26 2021-09-26 Preparation method of tris (hydroxymethyl) methylglycine
PCT/CN2022/111366 WO2023045601A1 (en) 2021-09-26 2022-08-10 Method for preparing tricine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111129423.XA CN113861053B (en) 2021-09-26 2021-09-26 Preparation method of tris (hydroxymethyl) methylglycine

Publications (2)

Publication Number Publication Date
CN113861053A true CN113861053A (en) 2021-12-31
CN113861053B CN113861053B (en) 2023-12-05

Family

ID=78994553

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111129423.XA Active CN113861053B (en) 2021-09-26 2021-09-26 Preparation method of tris (hydroxymethyl) methylglycine

Country Status (2)

Country Link
CN (1) CN113861053B (en)
WO (1) WO2023045601A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023045601A1 (en) * 2021-09-26 2023-03-30 苏州亚科科技股份有限公司 Method for preparing tricine

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU642299A1 (en) * 1977-09-26 1979-01-15 Научно-производственное объединение "Биохимреактив" Method of obtaining tricine
JP2008066588A (en) * 2006-09-08 2008-03-21 Fujifilm Corp Polishing solution
CN103880691A (en) * 2014-04-03 2014-06-25 重庆紫光国际化工有限责任公司 Clean and environment-friendly production method of N,N-dialkylglycine
CN108290849A (en) * 2015-12-10 2018-07-17 伯拉考成像股份公司 Contrast agent
CN112194590A (en) * 2020-10-16 2021-01-08 湖南韵邦生物医药有限公司 Preparation method of tri (hydroxymethyl) methylglycine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101402576B (en) * 2008-10-23 2011-03-23 浙江大学 Method for producing bi(2-hydroxyethyl)imino-tri(hydroxymethyl)methyl hydride
CN113861053B (en) * 2021-09-26 2023-12-05 苏州亚科科技股份有限公司 Preparation method of tris (hydroxymethyl) methylglycine

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU642299A1 (en) * 1977-09-26 1979-01-15 Научно-производственное объединение "Биохимреактив" Method of obtaining tricine
JP2008066588A (en) * 2006-09-08 2008-03-21 Fujifilm Corp Polishing solution
CN103880691A (en) * 2014-04-03 2014-06-25 重庆紫光国际化工有限责任公司 Clean and environment-friendly production method of N,N-dialkylglycine
CN108290849A (en) * 2015-12-10 2018-07-17 伯拉考成像股份公司 Contrast agent
CN112194590A (en) * 2020-10-16 2021-01-08 湖南韵邦生物医药有限公司 Preparation method of tri (hydroxymethyl) methylglycine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023045601A1 (en) * 2021-09-26 2023-03-30 苏州亚科科技股份有限公司 Method for preparing tricine

Also Published As

Publication number Publication date
CN113861053B (en) 2023-12-05
WO2023045601A1 (en) 2023-03-30

Similar Documents

Publication Publication Date Title
JP6995892B2 (en) Manufacturing method of Sugamadex
CN113861053B (en) Preparation method of tris (hydroxymethyl) methylglycine
MX2008000961A (en) Method for preparing 4beta-amino-4demethyl-4-desoxypodophyllotoxin.
CN111909060B (en) Preparation process of N- (2-acetamido) -2-aminoethanesulfonic acid
CN110759941B (en) Preparation method of D-gluconic acid-gamma-lactone and intermediate thereof
CN106518939B (en) Method for preparing Solithromycin compound
CN114369129A (en) Synthetic method of chlorinated nicotinamide ribose
JP4796776B2 (en) Method for producing 4,4'-dicarboxy-2,2'-bipyridine
CN116102531B (en) Preparation method of salicyl fluorone
US4196132A (en) Continuous flow process for the preparation of o-chloranil from tetrachlorocatechol
CN110015980A (en) A kind of method of synthesizing tertiary butyl sulfenamide
CN112142629B (en) Preparation method of 3-aminosulfonylalanine
CN114591187B (en) Preparation method of 1,3-bis (tris (hydroxymethyl) methylamino) propane
RU2122544C1 (en) Method of preparing n-tert-butyl-2-benzthiazole sulfeneamide
CN114835574A (en) Preparation process of 3-methyl sodium salicylate
CN109535025B (en) Preparation method of Evonib intermediate 3, 3-difluorocyclobutylamine hydrochloride
CN1683388A (en) Process for producing fluocinone intermediate 6aF
JPH02121962A (en) Production of mercaptocarboxylic acid
CN115850156A (en) Method for purifying difluoride compound
CN115124536A (en) Synthesis method of ibrutinib intermediate
CN116023292A (en) Synthesis method of phenyldiamine hydrochloride
CN116751173A (en) Green synthesis method of drug intermediate
CN115057768A (en) Synthetic method of 3, 5-dichloro-4-methoxybenzoic acid
CN117658837A (en) Preparation process of 5-aminolevulinic acid and salt thereof
US7157583B2 (en) Process for producing high-purity 2,3-pyridinedicarboxylic acid

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant